110162,0,Admission,O
110162,0,Date,O
110162,0,:,O
110162,0,[,O
110162,0,*,O
110162,0,*,O
110162,0,2119-4-6,O
110162,0,*,O
110162,0,*,O
110162,0,],O
110162,0,Discharge,O
110162,0,Date,O
110162,0,:,O
110162,0,[,O
110162,0,*,O
110162,0,*,O
110162,0,2119-4-15,O
110162,0,*,O
110162,0,*,O
110162,0,],O
110162,0,Service,O
110162,0,:,O
110162,0,MEDICINE,O
110162,0,Allergies,O
110162,0,:,O
110162,0,Bactrim,B-Drug
110162,0,Ds,O
110162,0,/,O
110162,0,Zyprexa,B-Drug
110162,0,/,O
110162,0,Lisinopril,B-Drug
110162,0,Attending,O
110162,0,:,O
110162,0,[,O
110162,0,*,O
110162,0,*,O
110162,0,First,O
110162,0,Name3,O
110162,0,(,O
110162,0,LF,O
110162,0,),O
110162,0,552,O
110162,0,*,O
110162,0,*,O
110162,0,],O
110162,0,Chief,O
110162,0,Complaint,O
110162,0,:,O
110162,0,Altered,O
110162,0,Mental,O
110162,0,Status,O
110162,0,Major,O
110162,0,Surgical,O
110162,0,or,O
110162,0,Invasive,O
110162,0,Procedure,O
110162,0,:,O
110162,0,CT,O
110162,0,head,O
110162,0,MRI/MRA,O
110162,0,LP,O
110162,0,Larynoscopy,O
110162,0,History,O
110162,0,of,O
110162,0,Present,O
110162,0,Illness,O
110162,0,:,O
110162,0,HPI,O
110162,0,:,O
110162,0,The,O
110162,0,patient,O
110162,0,is,O
110162,0,an,O
110162,0,88,O
110162,0,year,O
110162,0,old,O
110162,0,female,O
110162,0,",",O
110162,0,resident,O
110162,0,at,O
110162,0,[,O
110162,0,*,O
110162,0,*,O
110162,0,First,O
110162,0,Name5,O
110162,0,(,O
110162,0,NamePattern1,O
110162,0,),O
110162,0,553,O
110162,0,*,O
110162,0,*,O
110162,0,],O
110162,0,[,O
110162,0,*,O
110162,0,*,O
110162,0,Last,O
110162,0,Name,O
110162,0,(,O
110162,0,NamePattern1,O
110162,0,),O
110162,1,554,O
110162,1,*,O
110162,1,*,O
110162,1,],O
110162,1,[,O
110162,1,*,O
110162,1,*,O
110162,1,Hospital3,O
110162,1,*,O
110162,1,*,O
110162,1,],O
110162,1,",",O
110162,1,with,O
110162,1,medical,O
110162,1,history,O
110162,1,pertinent,O
110162,1,for,O
110162,1,Parkinson,O
110162,1,'s,O
110162,1,disease,O
110162,1,",",O
110162,1,Diabetes,O
110162,1,",",O
110162,1,and,O
110162,1,recent,O
110162,1,cornea,O
110162,1,transplant,O
110162,1,who,O
110162,1,now,O
110162,1,presents,O
110162,1,with,O
110162,1,altered,O
110162,1,mental,O
110162,1,status,O
110162,1,.,O
110162,1,Per,O
110162,1,last,O
110162,1,progress,O
110162,1,note,O
110162,1,from,O
110162,1,patient,O
110162,1,'s,O
110162,1,PCP,O
110162,1,",",O
110162,1,[,O
110162,1,*,O
110162,1,*,O
110162,1,Name10,O
110162,1,(,O
110162,1,NameIs,O
110162,1,),O
110162,1,*,O
110162,1,*,O
110162,1,],O
110162,1,patient,O
110162,1,has,O
110162,1,been,O
110162,1,in,O
110162,1,her,O
110162,1,usual,O
110162,1,state,O
110162,1,of,O
110162,1,health,O
110162,1,with,O
110162,1,exception,O
110162,1,of,O
110162,1,management,O
110162,1,of,O
110162,1,a,O
110162,1,cervical,O
110162,1,vertebral,O
110162,1,fracture,O
110162,1,secondary,O
110162,1,to,O
110162,1,fall,O
110162,1,as,O
110162,1,well,O
110162,1,as,O
110162,1,plans,O
110162,1,for,O
110162,1,a,O
110162,1,repat,O
110162,1,penetrating,O
110162,1,keratoplasty,O
110162,1,(,O
110162,1,corneal,O
110162,1,transplant,O
110162,1,),O
110162,1,s/p,O
110162,1,failed,O
110162,1,prior,O
110162,1,.,O
110162,2,The,O
110162,2,patient,O
110162,2,was,O
110162,2,at,O
110162,2,that,O
110162,2,time,O
110162,2,apparently,O
110162,2,at,O
110162,2,her,O
110162,2,baseline,O
110162,2,and,O
110162,2,cleared,O
110162,2,for,O
110162,2,surgery,O
110162,2,.,O
110162,2,The,O
110162,2,patient,O
110162,2,underwent,O
110162,2,penetrating,O
110162,2,keratoplasty,O
110162,2,on,O
110162,2,[,O
110162,2,*,O
110162,2,*,O
110162,2,2119-3-30,O
110162,2,*,O
110162,2,*,O
110162,2,],O
110162,2,for,O
110162,2,indication,O
110162,2,of,O
110162,2,failed,O
110162,2,graft,O
110162,2,without,O
110162,2,complication,O
110162,2,.,O
110162,2,The,O
110162,2,patient,O
110162,2,was,O
110162,2,seen,O
110162,2,by,O
110162,2,her,O
110162,2,ophthalmologist,O
110162,2,on,O
110162,2,[,O
110162,2,*,O
110162,2,*,O
110162,2,2119-4-4,O
110162,2,*,O
110162,2,*,O
110162,2,],O
110162,2,with,O
110162,2,impression,O
110162,2,that,O
110162,2,there,O
110162,2,was,O
110162,2,moderate,O
110162,2,lid,O
110162,2,edema,O
110162,2,present,O
110162,2,suggestive,O
110162,2,of,O
110162,2,hypersensitivity,O
110162,2,but,O
110162,2,no,O
110162,2,discharge,O
110162,2,to,O
110162,2,suggest,O
110162,2,infection,O
110162,2,.,O
110162,2,Polysporin,B-Drug
110162,2,was,O
110162,2,discontinued,O
110162,2,(,O
110162,2,with,O
110162,2,concern,O
110162,2,for,O
110162,2,hypersensitivty,B-ADE
110162,2,per,O
110162,2,discussion,O
110162,2,with,O
110162,2,daughter,O
110162,2,),O
110162,2,and,O
110162,2,other,O
110162,2,meds,O
110162,2,(,O
110162,2,Pred,B-Drug
110162,2,1,O
110162,2,%,O
110162,2,TID,O
110162,2,OS,O
110162,2,",",O
110162,2,Timolol,B-Drug
110162,2,0.5,O
110162,2,%,O
110162,2,[,O
110162,2,*,O
110162,2,*,O
110162,2,Hospital1,O
110162,3,*,O
110162,3,*,O
110162,3,],O
110162,3,OU,O
110162,3,",",O
110162,3,Xalatan,B-Drug
110162,3,QHS,O
110162,3,OS,O
110162,3,",",O
110162,3,Tobradex,B-Drug
110162,3,[,O
110162,3,*,O
110162,3,*,O
110162,3,Doctor,O
110162,3,Last,O
110162,3,Name,O
110162,3,*,O
110162,3,*,O
110162,3,],O
110162,3,OS,O
110162,3,QHS,O
110162,3,),O
110162,3,continued,O
110162,3,.,O
110162,3,The,O
110162,3,patient,O
110162,3,now,O
110162,3,presents,O
110162,3,form,O
110162,3,her,O
110162,3,[,O
110162,3,*,O
110162,3,*,O
110162,3,Hospital3,O
110162,3,*,O
110162,3,*,O
110162,3,],O
110162,3,with,O
110162,3,concern,O
110162,3,for,O
110162,3,altered,O
110162,3,mental,O
110162,3,status,O
110162,3,.,O
110162,3,Only,O
110162,3,limited,O
110162,3,information,O
110162,3,is,O
110162,3,available,O
110162,3,from,O
110162,3,available,O
110162,3,staff,O
110162,3,at,O
110162,3,[,O
110162,3,*,O
110162,3,*,O
110162,3,Hospital3,O
110162,3,400,O
110162,3,*,O
110162,3,*,O
110162,3,],O
110162,3,",",O
110162,3,with,O
110162,3,report,O
110162,3,only,O
110162,3,that,O
110162,3,patient,O
110162,3,was,O
110162,3,noted,O
110162,3,tonight,O
110162,3,to,O
110162,3,be,O
110162,3,acutely,O
110162,3,confused,O
110162,3,and,O
110162,3,``,O
110162,3,not,O
110162,3,making,O
110162,3,sense,O
110162,3,'',O
110162,3,.,O
110162,4,Per,O
110162,4,discussion,O
110162,4,with,O
110162,4,the,O
110162,4,patient,O
110162,4,'s,O
110162,4,daughter,O
110162,4,",",O
110162,4,the,O
110162,4,patient,O
110162,4,was,O
110162,4,in,O
110162,4,her,O
110162,4,usual,O
110162,4,state,O
110162,4,of,O
110162,4,health,O
110162,4,as,O
110162,4,early,O
110162,4,as,O
110162,4,yesterday,O
110162,4,morning,O
110162,4,",",O
110162,4,looking,O
110162,4,well,O
110162,4,.,O
110162,4,Later,O
110162,4,in,O
110162,4,the,O
110162,4,day,O
110162,4,",",O
110162,4,the,O
110162,4,patient,O
110162,4,was,O
110162,4,reported,O
110162,4,to,O
110162,4,be,O
110162,4,walking,O
110162,4,up,O
110162,4,and,O
110162,4,down,O
110162,4,the,O
110162,4,hallway,O
110162,4,",",O
110162,4,refusing,O
110162,4,to,O
110162,4,go,O
110162,4,to,O
110162,4,her,O
110162,4,room,O
110162,4,.,O
110162,4,The,O
110162,4,patient,O
110162,4,was,O
110162,4,noted,O
110162,4,to,O
110162,4,be,O
110162,4,shivering,O
110162,4,and,O
110162,4,unsteady,O
110162,4,on,O
110162,4,her,O
110162,4,feet,O
110162,4,.,O
110162,4,Recommendation,O
110162,4,was,O
110162,4,made,O
110162,4,that,O
110162,4,patient,O
110162,4,be,O
110162,4,sent,O
110162,4,to,O
110162,4,hospital,O
110162,4,for,O
110162,4,further,O
110162,4,evaluation,O
110162,4,.,O
110162,5,Per,O
110162,5,discussion,O
110162,5,with,O
110162,5,daughter,O
110162,5,",",O
110162,5,the,O
110162,5,patient,O
110162,5,has,O
110162,5,had,O
110162,5,prior,O
110162,5,episodes,O
110162,5,of,O
110162,5,confusion,O
110162,5,in,O
110162,5,setting,O
110162,5,of,O
110162,5,underlying,O
110162,5,infetion,O
110162,5,",",O
110162,5,usually,O
110162,5,UTI,O
110162,5,.,O
110162,5,.,O
110162,5,ED,O
110162,5,Course,O
110162,5,:,O
110162,5,98.4,O
110162,5,-,O
110162,5,>,O
110162,5,102.8,O
110162,5,rectal,O
110162,5,",",O
110162,5,186/84,O
110162,5,",",O
110162,5,85,O
110162,5,",",O
110162,5,20,O
110162,5,",",O
110162,5,93,O
110162,5,%,O
110162,5,RA,O
110162,5,.,O
110162,5,Labs,O
110162,5,notable,O
110162,5,for,O
110162,5,WBC,O
110162,5,8.0,O
110162,5,",",O
110162,5,lactate,O
110162,5,1.8,O
110162,5,.,O
110162,5,Not,O
110162,5,signed,O
110162,5,out,O
110162,5,",",O
110162,5,but,O
110162,5,per,O
110162,5,nursing,O
110162,5,report,O
110162,5,and,O
110162,5,discussion,O
110162,5,a,O
110162,5,central,O
110162,5,line,O
110162,5,was,O
110162,5,attempted,O
110162,5,given,O
110162,5,poor,O
110162,5,PIV,O
110162,5,access,O
110162,5,for,O
110162,5,which,O
110162,5,the,O
110162,5,patient,O
110162,5,received,O
110162,5,Haldol,B-Drug
110162,5,.,O
110162,6,No,O
110162,6,documentation,O
110162,6,of,O
110162,6,dose,O
110162,6,is,O
110162,6,available,O
110162,6,",",O
110162,6,[,O
110162,6,*,O
110162,6,*,O
110162,6,Name8,O
110162,6,(,O
110162,6,MD,O
110162,6,),O
110162,6,*,O
110162,6,*,O
110162,6,],O
110162,6,RN,O
110162,6,to,O
110162,6,RN,O
110162,6,signout,O
110162,6,this,O
110162,6,was,O
110162,6,5mg,O
110162,6,IV,O
110162,6,.,O
110162,6,Central,O
110162,6,line,O
110162,6,was,O
110162,6,not,O
110162,6,successfully,O
110162,6,placed,O
110162,6,and,O
110162,6,ultimately,O
110162,6,a,O
110162,6,22,O
110162,6,PIV,O
110162,6,in,O
110162,6,the,O
110162,6,hand,O
110162,6,was,O
110162,6,obtained,O
110162,6,.,O
110162,6,The,O
110162,6,patient,O
110162,6,had,O
110162,6,a,O
110162,6,negative,O
110162,6,UA,O
110162,6,",",O
110162,6,CXR,O
110162,6,without,O
110162,6,obvious,O
110162,6,infiltrate,O
110162,6,although,O
110162,6,limited,O
110162,6,.,O
110162,6,Ophthalmology,O
110162,6,was,O
110162,6,not,O
110162,6,contact,O
110162,6,[,O
110162,6,*,O
110162,6,*,O
110162,6,Name,O
110162,6,(,O
110162,6,NI,O
110162,6,),O
110162,6,*,O
110162,6,*,O
110162,6,],O
110162,6,as,O
110162,6,[,O
110162,6,*,O
110162,6,*,O
110162,6,Name,O
110162,6,(,O
110162,6,NI,O
110162,6,),O
110162,6,*,O
110162,6,*,O
110162,6,],O
110162,6,impression,O
110162,6,was,O
110162,6,that,O
110162,6,eye,O
110162,6,was,O
110162,6,not,O
110162,6,infected,O
110162,6,.,O
110162,7,LP,O
110162,7,was,O
110162,7,recommended,O
110162,7,by,O
110162,7,ED,O
110162,7,but,O
110162,7,patients,O
110162,7,',O
110162,7,daughter,O
110162,7,declined,O
110162,7,this,O
110162,7,.,O
110162,7,The,O
110162,7,patient,O
110162,7,was,O
110162,7,given,O
110162,7,Azithromycin,B-Drug
110162,7,",",O
110162,7,Vancomycin,B-Drug
110162,7,",",O
110162,7,and,O
110162,7,Ceftriaxone,B-Drug
110162,7,empirically,O
110162,7,and,O
110162,7,is,O
110162,7,now,O
110162,7,admitted,O
110162,7,to,O
110162,7,the,O
110162,7,medical,O
110162,7,service,O
110162,7,for,O
110162,7,ongoing,O
110162,7,care,O
110162,7,.,O
110162,7,On,O
110162,7,arrival,O
110162,7,to,O
110162,7,floor,O
110162,7,patient,O
110162,7,is,O
110162,7,lethargic,O
110162,7,but,O
110162,7,wakes,O
110162,7,to,O
110162,7,voice,O
110162,7,.,O
110162,7,She,O
110162,7,answers,O
110162,7,questions,O
110162,7,although,O
110162,7,requires,O
110162,7,repeat,O
110162,7,questioning,O
110162,7,at,O
110162,7,times,O
110162,7,to,O
110162,7,wake,O
110162,7,her,O
110162,7,.,O
110162,7,Patient,O
110162,7,reports,O
110162,7,mild,O
110162,7,neck,O
110162,7,pain,O
110162,7,since,O
110162,7,having,O
110162,7,collar,O
110162,7,removed,O
110162,7,",",O
110162,7,denies,O
110162,7,headache,O
110162,7,",",O
110162,7,chest,O
110162,7,pain,O
110162,7,",",O
110162,7,dyspnea,O
110162,7,",",O
110162,7,abdominal,O
110162,7,pain,O
110162,7,or,O
110162,7,other,O
110162,7,localizing,O
110162,7,symptoms,O
110162,7,.,O
110162,8,Past,O
110162,8,Medical,O
110162,8,History,O
110162,8,:,O
110162,8,Parkinson,O
110162,8,'s,O
110162,8,Disease,O
110162,8,Dementia,O
110162,8,",",O
110162,8,mild,O
110162,8,Hypertension,O
110162,8,Hyperlipidemia,O
110162,8,Hypothyroidism,O
110162,8,Type,O
110162,8,II,O
110162,8,DM,O
110162,8,",",O
110162,8,diet,O
110162,8,controlled,O
110162,8,Pernicious,O
110162,8,anemia,O
110162,8,History,O
110162,8,of,O
110162,8,breast,O
110162,8,cancer,O
110162,8,Urge,O
110162,8,incontinence,O
110162,8,s/p,O
110162,8,penetrating,O
110162,8,keratoplasty,O
110162,8,[,O
110162,8,*,O
110162,8,*,O
110162,8,2119-3-30,O
110162,8,*,O
110162,8,*,O
110162,8,],O
110162,8,Cervical,O
110162,8,vertebral,O
110162,8,fracture,O
110162,8,Social,O
110162,8,History,O
110162,8,:,O
110162,8,She,O
110162,8,is,O
110162,8,widowed,O
110162,8,.,O
110162,8,She,O
110162,8,had,O
110162,8,a,O
110162,8,6-year,O
110162,8,history,O
110162,8,of,O
110162,8,tobacco,O
110162,8,use,O
110162,8,but,O
110162,8,quit,O
110162,8,decades,O
110162,8,ago,O
110162,8,.,O
110162,8,Her,O
110162,8,daughter,O
110162,8,is,O
110162,8,in,O
110162,8,her,O
110162,8,50s,O
110162,8,and,O
110162,8,is,O
110162,8,healthy,O
110162,8,.,O
110162,8,She,O
110162,8,denies,O
110162,8,alcohol,O
110162,8,use,O
110162,8,or,O
110162,8,abuse,O
110162,8,.,O
110162,9,She,O
110162,9,formerly,O
110162,9,taught,O
110162,9,English,O
110162,9,in,O
110162,9,[,O
110162,9,*,O
110162,9,*,O
110162,9,Country,O
110162,9,532,O
110162,9,*,O
110162,9,*,O
110162,9,],O
110162,9,;,O
110162,9,she,O
110162,9,also,O
110162,9,worked,O
110162,9,as,O
110162,9,an,O
110162,9,interpreter,O
110162,9,of,O
110162,9,[,O
110162,9,*,O
110162,9,*,O
110162,9,Doctor,O
110162,9,First,O
110162,9,Name,O
110162,9,533,O
110162,9,*,O
110162,9,*,O
110162,9,],O
110162,9,",",O
110162,9,Japanese,O
110162,9,",",O
110162,9,and,O
110162,9,English,O
110162,9,.,O
110162,9,Family,O
110162,9,History,O
110162,9,:,O
110162,9,Non-contributory,O
110162,9,Physical,O
110162,9,Exam,O
110162,9,:,O
110162,9,On,O
110162,9,admission,O
110162,9,:,O
110162,9,Vitals,O
110162,9,:,O
110162,9,98.3,O
110162,9,",",O
110162,9,136/74,O
110162,9,",",O
110162,9,76,O
110162,9,",",O
110162,9,20,O
110162,9,",",O
110162,9,94,O
110162,9,%,O
110162,9,RA,O
110162,9,General,O
110162,9,:,O
110162,9,elderly,O
110162,9,female,O
110162,9,.,O
110162,9,Lethargic,O
110162,9,but,O
110162,9,arousable,O
110162,9,to,O
110162,9,vocal,O
110162,9,stimuli,O
110162,9,.,O
110162,9,Only,O
110162,9,opens,O
110162,9,eyes,O
110162,9,after,O
110162,9,extensive,O
110162,9,coaching,O
110162,9,.,O
110162,10,Can,O
110162,10,answer,O
110162,10,questions,O
110162,10,but,O
110162,10,often,O
110162,10,does,O
110162,10,not,O
110162,10,respond,O
110162,10,the,O
110162,10,first,O
110162,10,time,O
110162,10,.,O
110162,10,HEENT,O
110162,10,:,O
110162,10,+,O
110162,10,mild,O
110162,10,erythema,O
110162,10,",",O
110162,10,yellow,O
110162,10,bruising,O
110162,10,",",O
110162,10,and,O
110162,10,mod,O
110162,10,edema,O
110162,10,periorbital,O
110162,10,edema,O
110162,10,surrounding,O
110162,10,left,O
110162,10,eye,O
110162,10,.,O
110162,10,PERRL,O
110162,10,Mouth,O
110162,10,:,O
110162,10,Significant,O
110162,10,tongue,O
110162,10,swelling,O
110162,10,and,O
110162,10,swollen,O
110162,10,lower,O
110162,10,lip,O
110162,10,.,O
110162,10,Barely,O
110162,10,able,O
110162,10,to,O
110162,10,visualize,O
110162,10,uvula,O
110162,10,when,O
110162,10,using,O
110162,10,a,O
110162,10,tongue,O
110162,10,depressor,O
110162,10,.,O
110162,10,No,O
110162,10,erythema,O
110162,10,of,O
110162,10,the,O
110162,10,mouth,O
110162,10,.,O
110162,10,Neck,O
110162,10,:,O
110162,10,No,O
110162,10,LAD,O
110162,10,Chest,O
110162,10,:,O
110162,10,Difficult,O
110162,10,to,O
110162,10,access,O
110162,10,given,O
110162,10,pt,O
110162,10,intermittently,O
110162,10,snoring,O
110162,10,during,O
110162,10,exam,O
110162,10,despite,O
110162,10,repeatedly,O
110162,10,waking,O
110162,10,her,O
110162,10,up,O
110162,10,.,O
110162,11,No,O
110162,11,obvious,O
110162,11,crackles,O
110162,11,.,O
110162,11,Cardiac,O
110162,11,:,O
110162,11,RRR,O
110162,11,",",O
110162,11,III/VI,O
110162,11,systolic,O
110162,11,murmur,O
110162,11,loudest,O
110162,11,at,O
110162,11,LLSB,O
110162,11,Abdomen,O
110162,11,:,O
110162,11,+,O
110162,11,bs,O
110162,11,",",O
110162,11,soft,O
110162,11,",",O
110162,11,NTND,O
110162,11,",",O
110162,11,no,O
110162,11,HSM,O
110162,11,Ext,O
110162,11,:,O
110162,11,erythema,O
110162,11,bilaterally,O
110162,11,at,O
110162,11,ankles,O
110162,11,with,O
110162,11,no,O
110162,11,skin,O
110162,11,breakdown,O
110162,11,",",O
110162,11,DP,O
110162,11,pulses,O
110162,11,and,O
110162,11,PT,O
110162,11,pulses,O
110162,11,+1,O
110162,11,",",O
110162,11,radial,O
110162,11,pulses,O
110162,11,+,O
110162,11,[,O
110162,11,*,O
110162,11,*,O
110162,11,12-30,O
110162,11,*,O
110162,11,*,O
110162,11,],O
110162,11,.,O
110162,11,No,O
110162,11,c/c/e,O
110162,11,.,O
110162,11,Neuro,O
110162,11,:,O
110162,11,oriented,O
110162,11,to,O
110162,11,name,O
110162,11,only,O
110162,11,.,O
110162,11,States,O
110162,11,she,O
110162,11,is,O
110162,11,in,O
110162,11,her,O
110162,11,apartment,O
110162,11,.,O
110162,11,UE,O
110162,11,reflexes,O
110162,11,+2,O
110162,11,",",O
110162,11,LE,O
110162,11,reflexes,O
110162,11,difficult,O
110162,11,to,O
110162,11,access,O
110162,11,as,O
110162,11,pt,O
110162,11,not,O
110162,11,relaxing,O
110162,11,and,O
110162,11,is,O
110162,11,pulling,O
110162,11,away,O
110162,11,from,O
110162,11,babinski,O
110162,11,.,O
110162,12,Motor,O
110162,12,:,O
110162,12,Due,O
110162,12,to,O
110162,12,lethargy,O
110162,12,pt,O
110162,12,has,O
110162,12,poor,O
110162,12,participation,O
110162,12,in,O
110162,12,exam,O
110162,12,.,O
110162,12,UE,O
110162,12,strength,O
110162,12,4-/5,O
110162,12,except,O
110162,12,for,O
110162,12,grip,O
110162,12,[,O
110162,12,*,O
110162,12,*,O
110162,12,5-2,O
110162,12,*,O
110162,12,*,O
110162,12,],O
110162,12,bilaterally,O
110162,12,.,O
110162,12,LE,O
110162,12,poor,O
110162,12,effort,O
110162,12,.,O
110162,12,Sensation,O
110162,12,:,O
110162,12,Intact,O
110162,12,in,O
110162,12,face,O
110162,12,",",O
110162,12,UE,O
110162,12,and,O
110162,12,LE,O
110162,12,to,O
110162,12,touch,O
110162,12,Pertinent,O
110162,12,Results,O
110162,12,:,O
110162,12,[,O
110162,12,*,O
110162,12,*,O
110162,12,2119-4-5,O
110162,12,*,O
110162,12,*,O
110162,12,],O
110162,12,08:25PM,O
110162,12,GLUCOSE-145,O
110162,12,*,O
110162,12,UREA,O
110162,12,N-24,O
110162,12,*,O
110162,12,CREAT-0.8,O
110162,12,SODIUM-139,O
110162,12,POTASSIUM-4.4,O
110162,12,CHLORIDE-104,O
110162,12,TOTAL,O
110162,12,CO2-24,O
110162,12,ANION,O
110162,12,GAP-15,O
110162,12,[,O
110162,12,*,O
110162,12,*,O
110162,12,2119-4-5,O
110162,12,*,O
110162,12,*,O
110162,12,],O
110162,12,08:25PM,O
110162,12,ALT,O
110162,12,(,O
110162,12,SGPT,O
110162,12,),O
110162,12,-16,O
110162,12,AST,O
110162,12,(,O
110162,12,SGOT,O
110162,12,),O
110162,12,-27,O
110162,12,LD,O
110162,12,(,O
110162,12,LDH,O
110162,12,),O
110162,12,-261,O
110162,12,*,O
110162,12,CK,O
110162,12,(,O
110162,12,CPK,O
110162,12,),O
110162,12,-49,O
110162,12,ALK,O
110162,12,PHOS-129,O
110162,12,*,O
110162,12,AMYLASE-35,O
110162,12,TOT,O
110162,13,BILI-0.3,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,2119-4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,08:25PM,O
110162,13,LIPASE-23,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,2119-4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,08:25PM,O
110162,13,CK-MB-NotDone,O
110162,13,cTropnT-,O
110162,13,<,O
110162,13,0.01,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,2119-4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,08:25PM,O
110162,13,ALBUMIN-4.0,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,2119-4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,08:25PM,O
110162,13,WBC-8.0,O
110162,13,RBC-4.42,O
110162,13,HGB-13.1,O
110162,13,HCT-37.5,O
110162,13,MCV-85,O
110162,13,MCH-29.7,O
110162,13,MCHC-35.0,O
110162,13,RDW-15.1,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,2119-4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,08:25PM,O
110162,13,NEUTS-75.4,O
110162,13,*,O
110162,13,LYMPHS-17.2,O
110162,13,*,O
110162,13,MONOS-6.0,O
110162,13,EOS-1.3,O
110162,13,BASOS-0.2,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,2119-4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,08:25PM,O
110162,13,PLT,O
110162,13,COUNT-152,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,2119-4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,08:25PM,O
110162,13,PT-13.6,O
110162,13,*,O
110162,13,PTT-24.4,O
110162,13,INR,O
110162,13,(,O
110162,13,PT,O
110162,13,),O
110162,13,-1.2,O
110162,13,*,O
110162,13,CT,O
110162,13,head,O
110162,13,[,O
110162,13,*,O
110162,13,*,O
110162,13,4-5,O
110162,13,*,O
110162,13,*,O
110162,13,],O
110162,13,:,O
110162,13,1,O
110162,14,.,O
110162,14,No,O
110162,14,acute,O
110162,14,intracranial,O
110162,14,hemorrhage,O
110162,14,or,O
110162,14,acute,O
110162,14,fracture,O
110162,14,.,O
110162,14,2,O
110162,14,.,O
110162,14,Diffuse,O
110162,14,cerebral,O
110162,14,atrophy,O
110162,14,with,O
110162,14,moderate,O
110162,14,sulcal,O
110162,14,and,O
110162,14,ventricular,O
110162,14,prominence,O
110162,14,.,O
110162,14,3,O
110162,14,.,O
110162,14,Chronic,O
110162,14,microvascular,O
110162,14,infarcts,O
110162,14,",",O
110162,14,unchanged,O
110162,14,.,O
110162,14,4,O
110162,14,.,O
110162,14,Paranasal,O
110162,14,sinus,O
110162,14,disease,O
110162,14,as,O
110162,14,described,O
110162,14,",",O
110162,14,likely,O
110162,14,acute,O
110162,14,in,O
110162,14,the,O
110162,14,sphenoid,O
110162,14,sinus,O
110162,14,.,O
110162,14,CT,O
110162,14,neck,O
110162,14,[,O
110162,14,*,O
110162,14,*,O
110162,14,4-6,O
110162,14,*,O
110162,14,*,O
110162,14,],O
110162,14,:,O
110162,14,1,O
110162,14,.,O
110162,14,Significant,O
110162,14,swelling/inflammation,O
110162,14,of,O
110162,14,the,O
110162,14,soft,O
110162,14,tissues,O
110162,14,at,O
110162,14,the,O
110162,14,base,O
110162,14,of,O
110162,14,tongue,O
110162,14,",",O
110162,14,oropharynx,O
110162,14,",",O
110162,14,with,O
110162,14,fullness,O
110162,14,in,O
110162,14,the,O
110162,14,vallecula,O
110162,14,and,O
110162,14,the,O
110162,14,piriform,O
110162,14,sinuses,O
110162,14,",",O
110162,14,overall,O
110162,14,resulting,O
110162,14,in,O
110162,14,moderate,O
110162,14,to,O
110162,14,marked,O
110162,14,narrowing,O
110162,14,of,O
110162,14,the,O
110162,14,oropharynx,O
110162,14,.,O
110162,15,The,O
110162,15,etiology,O
110162,15,of,O
110162,15,this,O
110162,15,finding,O
110162,15,is,O
110162,15,uncertain,O
110162,15,from,O
110162,15,the,O
110162,15,present,O
110162,15,study,O
110162,15,.,O
110162,15,To,O
110162,15,correlate,O
110162,15,with,O
110162,15,direct,O
110162,15,ENT,O
110162,15,examination,O
110162,15,.,O
110162,15,2,O
110162,15,.,O
110162,15,Fullness,O
110162,15,of,O
110162,15,the,O
110162,15,hypopharynx,O
110162,15,and,O
110162,15,adjacent,O
110162,15,portions,O
110162,15,of,O
110162,15,esophagus,O
110162,15,-,O
110162,15,no,O
110162,15,adequately,O
110162,15,assessed,O
110162,15,on,O
110162,15,the,O
110162,15,present,O
110162,15,study-,O
110162,15,further,O
110162,15,evaluation,O
110162,15,recommended,O
110162,15,.,O
110162,15,3,O
110162,15,.,O
110162,15,Increased,O
110162,15,attenuation,O
110162,15,of,O
110162,15,the,O
110162,15,fat,O
110162,15,in,O
110162,15,the,O
110162,15,carotid,O
110162,15,space,O
110162,15,",",O
110162,15,with,O
110162,15,soft,O
110162,15,tissue,O
110162,15,attenuation,O
110162,15,opacity,O
110162,15,",",O
110162,15,with,O
110162,15,heterogeneous,O
110162,15,appearance,O
110162,15,",",O
110162,15,causing,O
110162,15,indentation,O
110162,15,on,O
110162,15,the,O
110162,15,right,O
110162,15,internal,O
110162,15,jugular,O
110162,15,vein,O
110162,15,extending,O
110162,15,down,O
110162,15,along,O
110162,15,the,O
110162,15,carotid,O
110162,15,space,O
110162,15,",",O
110162,15,into,O
110162,15,the,O
110162,15,region,O
110162,15,of,O
110162,15,the,O
110162,15,thoracic,O
110162,15,inlet,O
110162,15,.,O
110162,16,This,O
110162,16,may,O
110162,16,relate,O
110162,16,to,O
110162,16,inflammation,O
110162,16,",",O
110162,16,phlegmon,O
110162,16,",",O
110162,16,and,O
110162,16,radiation-related,O
110162,16,changes,O
110162,16,if,O
110162,16,there,O
110162,16,is,O
110162,16,history,O
110162,16,of,O
110162,16,radiation,O
110162,16,in,O
110162,16,the,O
110162,16,past,O
110162,16,and,O
110162,16,less,O
110162,16,likely,O
110162,16,neoplastic,O
110162,16,.,O
110162,16,Close,O
110162,16,followup,O
110162,16,evaluation,O
110162,16,",",O
110162,16,with,O
110162,16,ultrasound,O
110162,16,can,O
110162,16,be,O
110162,16,considered,O
110162,16,to,O
110162,16,evaluate,O
110162,16,for,O
110162,16,any,O
110162,16,abscess,O
110162,16,",",O
110162,16,given,O
110162,16,the,O
110162,16,patient,O
110162,16,'s,O
110162,16,symptoms,O
110162,16,of,O
110162,16,fever,O
110162,16,.,O
110162,16,CT,O
110162,16,orbits,O
110162,16,:,O
110162,16,1,O
110162,16,.,O
110162,16,Increased,O
110162,16,attenuation,O
110162,16,of,O
110162,16,the,O
110162,16,preseptal,O
110162,16,soft,O
110162,16,tissues,O
110162,16,with,O
110162,16,some,O
110162,16,enhancement,O
110162,16,",",O
110162,16,on,O
110162,16,the,O
110162,16,left,O
110162,16,side,O
110162,16,",",O
110162,16,likely,O
110162,16,due,O
110162,16,to,O
110162,16,inflamamtion/,O
110162,16,post-surgical,O
110162,16,changes-,O
110162,16,correlate,O
110162,16,with,O
110162,16,clinical,O
110162,16,examination,O
110162,16,.,O
110162,17,No,O
110162,17,definite,O
110162,17,abscess,O
110162,17,on,O
110162,17,the,O
110162,17,present,O
110162,17,set,O
110162,17,of,O
110162,17,images,O
110162,17,.,O
110162,17,No,O
110162,17,intraconal,O
110162,17,abnormality,O
110162,17,.,O
110162,17,F/u,O
110162,17,as,O
110162,17,clinically,O
110162,17,indicated,O
110162,17,.,O
110162,17,2,O
110162,17,.,O
110162,17,Moderate,O
110162,17,paranasal,O
110162,17,sinus,O
110162,17,disease,O
110162,17,CT,O
110162,17,head,O
110162,17,[,O
110162,17,*,O
110162,17,*,O
110162,17,4-9,O
110162,17,*,O
110162,17,*,O
110162,17,],O
110162,17,:,O
110162,17,1,O
110162,17,.,O
110162,17,No,O
110162,17,acute,O
110162,17,intracranial,O
110162,17,process,O
110162,17,.,O
110162,17,2,O
110162,17,.,O
110162,17,Persistent,O
110162,17,cerebral,O
110162,17,atrophy,O
110162,17,.,O
110162,17,3,O
110162,17,.,O
110162,17,Chronic,O
110162,17,microvascular,O
110162,17,ischemic,O
110162,17,changes,O
110162,17,.,O
110162,17,4,O
110162,17,.,O
110162,17,Paranasal,O
110162,17,sinus,O
110162,17,disease,O
110162,17,.,O
110162,17,MRI/MRA,O
110162,17,brain,O
110162,17,:,O
110162,17,Final,O
110162,17,Report,O
110162,17,HISTORY,O
110162,17,:,O
110162,17,Parkinson,O
110162,17,'s,O
110162,17,",",O
110162,17,delirium,O
110162,17,",",O
110162,17,lethargy,O
110162,17,",",O
110162,17,right,O
110162,17,facial,O
110162,17,droop,O
110162,17,and,O
110162,17,dysarthria,O
110162,17,.,O
110162,18,Evaluate,O
110162,18,for,O
110162,18,signs,O
110162,18,of,O
110162,18,intracranial,O
110162,18,hemorrhage,O
110162,18,or,O
110162,18,acute,O
110162,18,stroke,O
110162,18,.,O
110162,18,Comparison,O
110162,18,is,O
110162,18,made,O
110162,18,to,O
110162,18,most,O
110162,18,recent,O
110162,18,head,O
110162,18,CT,O
110162,18,of,O
110162,18,[,O
110162,18,*,O
110162,18,*,O
110162,18,2119-4-9,O
110162,18,*,O
110162,18,*,O
110162,18,],O
110162,18,TECHNIQUE,O
110162,18,:,O
110162,18,Multiplanar,O
110162,18,T1-,O
110162,18,and,O
110162,18,T2-weighted,O
110162,18,sequences,O
110162,18,were,O
110162,18,obtained,O
110162,18,through,O
110162,18,the,O
110162,18,brain,O
110162,18,without,O
110162,18,intravenous,O
110162,18,gadolinium,O
110162,18,.,O
110162,18,3D,O
110162,18,time-of-flight,O
110162,18,MR,O
110162,18,arteriography,O
110162,18,was,O
110162,18,also,O
110162,18,performed,O
110162,18,.,O
110162,18,Volume-rendering,O
110162,18,reconstructed,O
110162,18,images,O
110162,18,were,O
110162,18,evaluated,O
110162,18,.,O
110162,18,MRI,O
110162,18,OF,O
110162,18,THE,O
110162,18,BRAIN,O
110162,18,AND,O
110162,18,MRA,O
110162,18,OF,O
110162,18,THE,O
110162,18,BRAIN,O
110162,18,:,O
110162,18,There,O
110162,18,is,O
110162,18,no,O
110162,18,evidence,O
110162,18,of,O
110162,18,intracranial,O
110162,18,hemorrhage,O
110162,18,",",O
110162,18,masses,O
110162,18,",",O
110162,18,mass,O
110162,18,effect,O
110162,18,",",O
110162,18,or,O
110162,18,regions,O
110162,18,of,O
110162,18,restricted,O
110162,18,diffusion,O
110162,18,to,O
110162,18,suggest,O
110162,18,acute,O
110162,18,infarction,O
110162,18,.,O
110162,19,A,O
110162,19,few,O
110162,19,scattered,O
110162,19,periventricular,O
110162,19,T2/FLAIR,O
110162,19,hyperintensities,O
110162,19,are,O
110162,19,noted,O
110162,19,",",O
110162,19,which,O
110162,19,are,O
110162,19,nonspecific,O
110162,19,but,O
110162,19,likely,O
110162,19,suggest,O
110162,19,chronic,O
110162,19,small,O
110162,19,vessel,O
110162,19,ischemia,O
110162,19,.,O
110162,19,There,O
110162,19,are,O
110162,19,also,O
110162,19,adjacent,O
110162,19,prominent,O
110162,19,Virchow-,O
110162,19,[,O
110162,19,*,O
110162,19,*,O
110162,19,Doctor,O
110162,19,First,O
110162,19,Name,O
110162,19,*,O
110162,19,*,O
110162,19,],O
110162,19,spaces,O
110162,19,.,O
110162,19,While,O
110162,19,there,O
110162,19,is,O
110162,19,underlying,O
110162,19,global,O
110162,19,cerebral,O
110162,19,atrophy,O
110162,19,",",O
110162,19,the,O
110162,19,degree,O
110162,19,of,O
110162,19,dilatation,O
110162,19,of,O
110162,19,the,O
110162,19,ventricular,O
110162,19,system,O
110162,19,may,O
110162,19,be,O
110162,19,somewhat,O
110162,19,disproportionate,O
110162,19,to,O
110162,19,the,O
110162,19,amount,O
110162,19,of,O
110162,19,central,O
110162,19,atrophy,O
110162,19,.,O
110162,19,Small,O
110162,19,amount,O
110162,19,of,O
110162,19,fluid,O
110162,19,is,O
110162,19,noted,O
110162,19,in,O
110162,19,the,O
110162,19,mastoids,O
110162,19,bilateral,O
110162,19,.,O
110162,19,MR,O
110162,19,arteriography,O
110162,19,of,O
110162,19,the,O
110162,19,circle,O
110162,19,of,O
110162,19,[,O
110162,19,*,O
110162,19,*,O
110162,19,Location,O
110162,19,(,O
110162,19,un,O
110162,19,),O
110162,19,431,O
110162,19,*,O
110162,19,*,O
110162,19,],O
110162,19,displays,O
110162,19,no,O
110162,19,aneurysmal,O
110162,19,dilatation,O
110162,19,.,O
110162,20,Mild,O
110162,20,atherosclerosis,O
110162,20,is,O
110162,20,noted,O
110162,20,in,O
110162,20,the,O
110162,20,right,O
110162,20,M1,O
110162,20,segment,O
110162,20,.,O
110162,20,Posterior,O
110162,20,circulation,O
110162,20,is,O
110162,20,left,O
110162,20,dominant,O
110162,20,.,O
110162,20,IMPRESSION,O
110162,20,:,O
110162,20,1,O
110162,20,.,O
110162,20,No,O
110162,20,evidence,O
110162,20,of,O
110162,20,acute,O
110162,20,infarction,O
110162,20,.,O
110162,20,Scattered,O
110162,20,changes,O
110162,20,likely,O
110162,20,related,O
110162,20,to,O
110162,20,chronic,O
110162,20,small,O
110162,20,vessel,O
110162,20,ischemic,O
110162,20,disease,O
110162,20,.,O
110162,20,2,O
110162,20,.,O
110162,20,Question,O
110162,20,slightly,O
110162,20,disproportionate,O
110162,20,degree,O
110162,20,of,O
110162,20,ventricular,O
110162,20,dilatation,O
110162,20,in,O
110162,20,relation,O
110162,20,to,O
110162,20,the,O
110162,20,amount,O
110162,20,underlying,O
110162,20,cerebral,O
110162,20,atrophy,O
110162,20,.,O
110162,20,While,O
110162,20,this,O
110162,20,finding,O
110162,20,is,O
110162,20,nonspecific,O
110162,20,",",O
110162,20,in,O
110162,20,the,O
110162,20,appropriate,O
110162,20,clinical,O
110162,20,scenario,O
110162,20,it,O
110162,20,may,O
110162,20,reflect,O
110162,20,underlying,O
110162,20,NPH,O
110162,20,.,O
110162,20,Brief,O
110162,20,Hospital,O
110162,20,Course,O
110162,20,:,O
110162,20,This,O
110162,20,pt,O
110162,20,is,O
110162,20,a,O
110162,20,88yo,O
110162,20,female,O
110162,20,w,O
110162,20,h/o,O
110162,20,Parkinson,O
110162,20,'s,O
110162,20,disease,O
110162,20,",",O
110162,20,mild,O
110162,20,dementia,O
110162,20,and,O
110162,20,recent,O
110162,20,corneal,O
110162,20,transplant,O
110162,20,admitted,O
110162,20,to,O
110162,20,the,O
110162,20,hospital,O
110162,20,for,O
110162,20,AMS,O
110162,21,and,O
110162,21,to,O
110162,21,the,O
110162,21,ICU,O
110162,21,for,O
110162,21,airway,O
110162,21,narrowing,O
110162,21,.,O
110162,21,.,O
110162,21,#,O
110162,21,Airway,O
110162,21,narrowing,O
110162,21,:,O
110162,21,She,O
110162,21,was,O
110162,21,noted,O
110162,21,to,O
110162,21,have,O
110162,21,swelling,O
110162,21,of,O
110162,21,the,O
110162,21,tongue,O
110162,21,and,O
110162,21,lower,O
110162,21,lips,O
110162,21,on,O
110162,21,admission,O
110162,21,.,O
110162,21,A,O
110162,21,CT,B-Reason
110162,21,of,O
110162,21,the,O
110162,21,Head,O
110162,21,and,O
110162,21,Neck,O
110162,21,with,O
110162,21,IV,O
110162,21,contrast,B-Drug
110162,21,showed,O
110162,21,no,O
110162,21,clear,O
110162,21,evidence,O
110162,21,of,O
110162,21,preseptal,O
110162,21,cellulitis,O
110162,21,and,O
110162,21,?,O
110162,21,of,O
110162,21,soft,O
110162,21,tissue,O
110162,21,infection/edema,O
110162,21,of,O
110162,21,neck,O
110162,21,and,O
110162,21,throat,O
110162,21,.,O
110162,21,Over,O
110162,21,course,O
110162,21,of,O
110162,21,day,O
110162,21,",",O
110162,21,noted,O
110162,21,to,O
110162,21,have,O
110162,21,increased,O
110162,21,audible,O
110162,21,upper,O
110162,21,airway,O
110162,21,sounds,O
110162,21,with,O
110162,21,good,O
110162,21,O2,O
110162,21,sat,O
110162,21,of,O
110162,21,97,O
110162,21,%,O
110162,21,on,O
110162,21,2L,O
110162,21,which,O
110162,21,has,O
110162,21,been,O
110162,21,stable,O
110162,21,.,O
110162,22,ENT,O
110162,22,was,O
110162,22,consulted,O
110162,22,and,O
110162,22,saw,O
110162,22,extensive,O
110162,22,edema,O
110162,22,and,O
110162,22,soft,O
110162,22,tissue,O
110162,22,swelling,O
110162,22,in,O
110162,22,oropharynx,O
110162,22,with,O
110162,22,patent,O
110162,22,airway,O
110162,22,.,O
110162,22,Swelling,O
110162,22,around,O
110162,22,false,O
110162,22,cords,O
110162,22,",",O
110162,22,tonsillar,B-Reason
110162,22,edema,I-Reason
110162,22,",",O
110162,22,but,O
110162,22,true,O
110162,22,cords,O
110162,22,without,O
110162,22,edema,O
110162,22,.,O
110162,22,The,O
110162,22,team,O
110162,22,thought,O
110162,22,the,O
110162,22,swelling,B-Reason
110162,22,to,O
110162,22,be,O
110162,22,secondary,O
110162,22,to,O
110162,22,possible,O
110162,22,allergic,O
110162,22,reaction,O
110162,22,to,O
110162,22,medications,O
110162,22,.,O
110162,22,She,O
110162,22,was,O
110162,22,started,O
110162,22,on,O
110162,22,solumedrol,B-Drug
110162,22,60IV,O
110162,22,and,O
110162,22,famotidine,B-Drug
110162,22,20mg,O
110162,22,.,O
110162,22,She,O
110162,22,was,O
110162,22,given,O
110162,22,one,O
110162,22,dose,O
110162,22,of,O
110162,22,zosyn,B-Drug
110162,22,and,O
110162,22,then,O
110162,22,switched,O
110162,22,to,O
110162,22,unasyn,B-Drug
110162,22,to,O
110162,22,cover,O
110162,22,for,O
110162,22,possible,O
110162,22,soft,B-Reason
110162,22,tissue,I-Reason
110162,22,infection,I-Reason
110162,22,.,O
110162,23,Pt,O
110162,23,without,O
110162,23,leukocytosis,O
110162,23,",",O
110162,23,fever,O
110162,23,(,O
110162,23,was,O
110162,23,102.8,O
110162,23,in,O
110162,23,the,O
110162,23,ED,O
110162,23,but,O
110162,23,afebrile,O
110162,23,since,O
110162,23,),O
110162,23,",",O
110162,23,or,O
110162,23,abcess,O
110162,23,.,O
110162,23,ENT,O
110162,23,and,O
110162,23,anesthesia,O
110162,23,recommended,O
110162,23,transfer,O
110162,23,to,O
110162,23,ICU,O
110162,23,for,O
110162,23,further,O
110162,23,monitoring,O
110162,23,.,O
110162,23,She,O
110162,23,was,O
110162,23,monitored,O
110162,23,and,O
110162,23,continued,O
110162,23,on,O
110162,23,Decadron,B-Drug
110162,23,for,O
110162,23,three,O
110162,23,doses,O
110162,23,.,O
110162,23,During,O
110162,23,successive,O
110162,23,scopes,O
110162,23,by,O
110162,23,ENT,O
110162,23,",",O
110162,23,oropharyngeal,O
110162,23,edema,O
110162,23,and,O
110162,23,some,O
110162,23,secretions,O
110162,23,were,O
110162,23,seen,O
110162,23,",",O
110162,23,but,O
110162,23,airway,O
110162,23,remained,O
110162,23,patent,O
110162,23,.,O
110162,23,Unclear,O
110162,23,etiology,O
110162,23,:,O
110162,23,possible,O
110162,23,allergic,O
110162,23,reaction,O
110162,23,vs,O
110162,23,infectious,O
110162,23,process,O
110162,23,vs,O
110162,23,both,O
110162,23,given,O
110162,23,tonsils,O
110162,23,appear,O
110162,23,possibly,O
110162,23,infectious,O
110162,23,and,O
110162,23,lower,O
110162,23,airway,O
110162,23,appears,O
110162,23,more,O
110162,23,edematous,O
110162,23,and,O
110162,23,less,O
110162,23,infectious,O
110162,23,.,O
110162,24,Lisinopril,B-Drug
110162,24,was,O
110162,24,stopped,O
110162,24,",",O
110162,24,and,O
110162,24,her,O
110162,24,laryngoscopic,O
110162,24,exam,O
110162,24,visibly,O
110162,24,improved,O
110162,24,by,O
110162,24,the,O
110162,24,time,O
110162,24,she,O
110162,24,was,O
110162,24,called,O
110162,24,out,O
110162,24,to,O
110162,24,the,O
110162,24,floor,O
110162,24,.,O
110162,24,-Pt,O
110162,24,was,O
110162,24,treated,O
110162,24,for,O
110162,24,10,O
110162,24,days,O
110162,24,for,O
110162,24,?,O
110162,24,soft,B-Reason
110162,24,tissue,I-Reason
110162,24,infection,I-Reason
110162,24,and,O
110162,24,switched,O
110162,24,to,O
110162,24,Augmentin,B-Drug
110162,24,for,O
110162,24,additional,O
110162,24,5,O
110162,24,days,O
110162,24,at,O
110162,24,dc,O
110162,24,-ENT,O
110162,24,follow,O
110162,24,up,O
110162,24,appt,O
110162,24,was,O
110162,24,set,O
110162,24,up,O
110162,24,#,O
110162,24,s/p,O
110162,24,corneal,O
110162,24,TP,O
110162,24,:,O
110162,24,lid,O
110162,24,edema,O
110162,24,on,O
110162,24,exam,O
110162,24,.,O
110162,24,Ophtho,O
110162,24,believes,O
110162,24,likely,O
110162,24,secondary,O
110162,24,to,O
110162,24,blockage,O
110162,24,of,O
110162,24,drainage,O
110162,24,and,O
110162,24,not,O
110162,24,as,O
110162,24,likely,O
110162,24,due,O
110162,24,to,O
110162,24,allergy,O
110162,24,.,O
110162,24,Ophtho,O
110162,24,felt,O
110162,24,the,O
110162,24,eye,O
110162,24,was,O
110162,24,improving,O
110162,24,and,O
110162,24,recommended,O
110162,24,decreasing,O
110162,24,doses,O
110162,24,of,O
110162,24,eye,B-Drug
110162,24,drops,I-Drug
110162,24,.,O
110162,25,-FU,O
110162,25,appt,O
110162,25,with,O
110162,25,Optho,O
110162,25,set,O
110162,25,up,O
110162,25,.,O
110162,25,#,O
110162,25,.,O
110162,25,Altered,B-ADE
110162,25,Mental,I-ADE
110162,25,Status,I-ADE
110162,25,:,O
110162,25,On,O
110162,25,admission,O
110162,25,",",O
110162,25,she,O
110162,25,was,O
110162,25,lethargic,B-ADE
110162,25,",",O
110162,25,possibly,O
110162,25,from,O
110162,25,the,O
110162,25,Haldol,B-Drug
110162,25,she,O
110162,25,received,O
110162,25,in,O
110162,25,the,O
110162,25,ED,O
110162,25,.,O
110162,25,By,O
110162,25,the,O
110162,25,time,O
110162,25,she,O
110162,25,was,O
110162,25,called,O
110162,25,out,O
110162,25,of,O
110162,25,the,O
110162,25,ICU,O
110162,25,",",O
110162,25,she,O
110162,25,was,O
110162,25,likely,O
110162,25,at,O
110162,25,her,O
110162,25,baseline,O
110162,25,mental,O
110162,25,status,O
110162,25,",",O
110162,25,pleasant,O
110162,25,and,O
110162,25,easily,O
110162,25,conversant,O
110162,25,.,O
110162,25,Shortely,O
110162,25,thereafter,O
110162,25,",",O
110162,25,however,O
110162,25,",",O
110162,25,she,O
110162,25,became,O
110162,25,agitated,B-Reason
110162,25,and,O
110162,25,combative,B-Reason
110162,25,and,O
110162,25,received,O
110162,25,1.5mg,O
110162,25,Haldol,B-Drug
110162,25,and,O
110162,25,later,O
110162,25,the,O
110162,25,same,O
110162,25,day,O
110162,25,5mg,O
110162,25,of,O
110162,25,Zyprexa,B-Drug
110162,25,.,O
110162,26,She,O
110162,26,remained,O
110162,26,agitated,O
110162,26,for,O
110162,26,about,O
110162,26,36,O
110162,26,hours,O
110162,26,before,O
110162,26,she,O
110162,26,became,O
110162,26,lethargic,O
110162,26,and,O
110162,26,barely,O
110162,26,arousable,O
110162,26,.,O
110162,26,Head,O
110162,26,CT,O
110162,26,was,O
110162,26,unchanged,O
110162,26,from,O
110162,26,before,O
110162,26,.,O
110162,26,She,O
110162,26,had,O
110162,26,not,O
110162,26,had,O
110162,26,any,O
110162,26,new,O
110162,26,fevers,O
110162,26,or,O
110162,26,new,O
110162,26,signs,O
110162,26,of,O
110162,26,infection,O
110162,26,.,O
110162,26,She,O
110162,26,had,O
110162,26,a,O
110162,26,lumbar,O
110162,26,puncture,O
110162,26,that,O
110162,26,was,O
110162,26,unremarkable,O
110162,26,.,O
110162,26,MRI/MRA,O
110162,26,was,O
110162,26,neg,O
110162,26,except,O
110162,26,for,O
110162,26,some,O
110162,26,ventriculomegaly,O
110162,26,in,O
110162,26,setting,O
110162,26,of,O
110162,26,global,O
110162,26,atrophy,O
110162,26,which,O
110162,26,was,O
110162,26,difficult,O
110162,26,to,O
110162,26,differentiate,O
110162,26,from,O
110162,26,NPH,O
110162,26,.,O
110162,26,Neurology,O
110162,26,thought,O
110162,26,it,O
110162,26,was,O
110162,26,unlikely,O
110162,26,to,O
110162,26,be,O
110162,26,NPH,O
110162,26,.,O
110162,26,EEG,O
110162,26,showed,O
110162,26,some,O
110162,26,focal,O
110162,26,acitivity,O
110162,26,concerning,O
110162,26,for,O
110162,26,sublinical,B-Reason
110162,26,seizures,I-Reason
110162,26,.,O
110162,27,Pt,O
110162,27,was,O
110162,27,started,O
110162,27,on,O
110162,27,keppra,B-Drug
110162,27,",",O
110162,27,initially,O
110162,27,continued,O
110162,27,to,O
110162,27,have,O
110162,27,periods,O
110162,27,of,O
110162,27,somnolence,O
110162,27,along,O
110162,27,with,O
110162,27,R,O
110162,27,sided,O
110162,27,facial,O
110162,27,droop,O
110162,27,(,O
110162,27,which,O
110162,27,was,O
110162,27,thought,O
110162,27,be,O
110162,27,Neurology,O
110162,27,to,O
110162,27,represent,O
110162,27,a,O
110162,27,post-ictal,O
110162,27,state,O
110162,27,with,O
110162,27,[,O
110162,27,*,O
110162,27,*,O
110162,27,Doctor,O
110162,27,Last,O
110162,27,Name,O
110162,27,555,O
110162,27,*,O
110162,27,*,O
110162,27,],O
110162,27,paralysis,O
110162,27,),O
110162,27,but,O
110162,27,day,O
110162,27,before,O
110162,27,discharge,O
110162,27,had,O
110162,27,significant,O
110162,27,improvement,O
110162,27,in,O
110162,27,mental,O
110162,27,status,O
110162,27,and,O
110162,27,was,O
110162,27,alert,O
110162,27,and,O
110162,27,conversive,O
110162,27,.,O
110162,27,Due,O
110162,27,to,O
110162,27,hx,O
110162,27,of,O
110162,27,dementia,O
110162,27,and,O
110162,27,also,O
110162,27,ongoing,O
110162,27,hypoactive,O
110162,27,delirium,O
110162,27,",",O
110162,27,pt,O
110162,27,was,O
110162,27,not,O
110162,27,fully,O
110162,27,oriented,O
110162,27,but,O
110162,27,did,O
110162,27,have,O
110162,27,significant,O
110162,27,improvement,O
110162,27,in,O
110162,27,level,O
110162,27,of,O
110162,27,alertness,O
110162,27,.,O
110162,28,-Pt,O
110162,28,curently,O
110162,28,is,O
110162,28,on,O
110162,28,Keppra,B-Drug
110162,28,1000mg,O
110162,28,[,O
110162,28,*,O
110162,28,*,O
110162,28,Hospital1,O
110162,28,*,O
110162,28,*,O
110162,28,],O
110162,28,for,O
110162,28,one,O
110162,28,week,O
110162,28,and,O
110162,28,to,O
110162,28,be,O
110162,28,increased,O
110162,28,to,O
110162,28,1500mg,O
110162,28,[,O
110162,28,*,O
110162,28,*,O
110162,28,Hospital1,O
110162,28,*,O
110162,28,*,O
110162,28,],O
110162,28,later,O
110162,28,and,O
110162,28,kept,O
110162,28,at,O
110162,28,that,O
110162,28,dose,O
110162,28,.,O
110162,28,-Pt,O
110162,28,should,O
110162,28,be,O
110162,28,followed,O
110162,28,by,O
110162,28,a,O
110162,28,neurologist,O
110162,28,at,O
110162,28,[,O
110162,28,*,O
110162,28,*,O
110162,28,Hospital,O
110162,28,100,O
110162,28,*,O
110162,28,*,O
110162,28,],O
110162,28,Rehab,O
110162,28,-Outpt,O
110162,28,FU,O
110162,28,w,O
110162,28,neurology,O
110162,28,is,O
110162,28,already,O
110162,28,set,O
110162,28,up,O
110162,28,.,O
110162,28,#,O
110162,28,.,O
110162,28,UTI,B-Reason
110162,28,:,O
110162,28,grew,O
110162,28,Enterococcus,B-Reason
110162,28,in,O
110162,28,UCx,O
110162,28,.,O
110162,28,She,O
110162,28,was,O
110162,28,continued,O
110162,28,on,O
110162,28,Unasyn,B-Drug
110162,28,for,O
110162,28,10,O
110162,28,days,O
110162,28,.,O
110162,29,.,O
110162,29,#,O
110162,29,.,O
110162,29,Positive,O
110162,29,blood,O
110162,29,cultures,O
110162,29,:,O
110162,29,1/4,O
110162,29,bottles,O
110162,29,growing,O
110162,29,coag,O
110162,29,negative,O
110162,29,Staph,O
110162,29,.,O
110162,29,This,O
110162,29,was,O
110162,29,likely,O
110162,29,a,O
110162,29,contaminant,O
110162,29,so,O
110162,29,vancomycin,B-Drug
110162,29,was,O
110162,29,stopped,O
110162,29,.,O
110162,29,Repeat,O
110162,29,blood,O
110162,29,cultures,O
110162,29,were,O
110162,29,negative,O
110162,29,.,O
110162,29,#,O
110162,29,.,O
110162,29,Parkinson,B-Reason
110162,29,'s,I-Reason
110162,29,Disease,I-Reason
110162,29,:,O
110162,29,continued,O
110162,29,Sinemet,B-Drug
110162,29,except,O
110162,29,when,O
110162,29,patient,O
110162,29,was,O
110162,29,too,O
110162,29,lethargic,O
110162,29,to,O
110162,29,safely,O
110162,29,take,O
110162,29,meds,O
110162,29,.,O
110162,29,#,O
110162,29,.,O
110162,29,Hypertension,B-Reason
110162,29,",",I-Reason
110162,29,benign,I-Reason
110162,29,:,O
110162,29,Lisinopril,B-Drug
110162,29,was,O
110162,29,stopped,O
110162,29,due,O
110162,29,to,O
110162,29,concern,O
110162,29,of,O
110162,29,angioedema,B-ADE
110162,29,.,O
110162,29,Atenolol,B-Drug
110162,29,was,O
110162,29,continued,O
110162,29,.,O
110162,29,.,O
110162,29,#,O
110162,29,.,O
110162,29,Hyperlipidemia,B-Reason
110162,29,:,O
110162,29,continued,O
110162,29,statin,B-Drug
110162,29,.,O
110162,30,#,O
110162,30,.,O
110162,30,Hypothyroidism,B-Reason
110162,30,:,O
110162,30,TSH,O
110162,30,normal,O
110162,30,on,O
110162,30,[,O
110162,30,*,O
110162,30,*,O
110162,30,2119-4-6,O
110162,30,*,O
110162,30,*,O
110162,30,],O
110162,30,so,O
110162,30,not,O
110162,30,a,O
110162,30,picture,O
110162,30,of,O
110162,30,myxedema,O
110162,30,and,O
110162,30,can,O
110162,30,not,O
110162,30,account,O
110162,30,for,O
110162,30,MS,O
110162,30,change,O
110162,30,.,O
110162,30,Continued,O
110162,30,levothyroxine,B-Drug
110162,30,.,O
110162,30,#,O
110162,30,.,O
110162,30,Diabetes,B-Reason
110162,30,II,I-Reason
110162,30,",",O
110162,30,diet,O
110162,30,controlled,O
110162,30,without,O
110162,30,complication,O
110162,30,:,O
110162,30,-,O
110162,30,insulin,B-Drug
110162,30,sliding,O
110162,30,scale,O
110162,30,while,O
110162,30,inpatient,O
110162,30,and,O
110162,30,bs,O
110162,30,were,O
110162,30,wnl,O
110162,30,.,O
110162,30,Pt,O
110162,30,can,O
110162,30,have,O
110162,30,[,O
110162,30,*,O
110162,30,*,O
110162,30,Hospital1,O
110162,30,*,O
110162,30,*,O
110162,30,],O
110162,30,finger,O
110162,30,checks,O
110162,30,to,O
110162,30,Rehab,O
110162,30,but,O
110162,30,since,O
110162,30,not,O
110162,30,needing,O
110162,30,insulin,B-Drug
110162,30,",",O
110162,30,does,O
110162,30,not,O
110162,30,have,O
110162,30,to,O
110162,30,be,O
110162,30,on,O
110162,30,sliding,O
110162,30,scale,O
110162,30,#,O
110162,30,Deconditioning,O
110162,30,:,O
110162,30,per,O
110162,30,PT,O
110162,30,eval,O
110162,30,",",O
110162,30,pt,O
110162,30,was,O
110162,30,2,O
110162,30,person,O
110162,30,assist,O
110162,30,and,O
110162,30,will,O
110162,30,need,O
110162,30,significant,O
110162,30,PT,O
110162,30,therapy,O
110162,30,to,O
110162,30,get,O
110162,31,back,O
110162,31,to,O
110162,31,baseline,O
110162,31,where,O
110162,31,she,O
110162,31,was,O
110162,31,walking,O
110162,31,with,O
110162,31,a,O
110162,31,walker,O
110162,31,Medications,O
110162,31,on,O
110162,31,Admission,O
110162,31,:,O
110162,31,Tylenol,B-Drug
110162,31,1000mg,O
110162,31,PO,O
110162,31,twice,O
110162,31,daliy,O
110162,31,Aspirin,B-Drug
110162,31,81mg,O
110162,31,daily,O
110162,31,Atenolol,B-Drug
110162,31,25mg,O
110162,31,daily,O
110162,31,Carbidopa/Levodopa,B-Drug
110162,31,25/100mg,O
110162,31,three,O
110162,31,times,O
110162,31,daily,O
110162,31,Enablex,B-Drug
110162,31,7.5mg,O
110162,31,SR,O
110162,31,daily,O
110162,31,Fish,B-Drug
110162,31,Oil,I-Drug
110162,31,1000mg,O
110162,31,daily,O
110162,31,Levothyroxin,B-Drug
110162,31,125mcg,O
110162,31,daily,O
110162,31,Lisinopril,B-Drug
110162,31,20mg,O
110162,31,daily,O
110162,31,Simvastatin,B-Drug
110162,31,10mg,O
110162,31,daily,O
110162,31,Cyanocobalamin,B-Drug
110162,31,1000mcg,O
110162,31,daily,O
110162,31,Docusate,B-Drug
110162,31,100mg,O
110162,31,daily,O
110162,31,Pred,B-Drug
110162,31,1,O
110162,31,%,O
110162,31,TID,O
110162,31,OS,O
110162,31,Timolol,B-Drug
110162,31,0.5,O
110162,31,%,O
110162,31,[,O
110162,31,*,O
110162,31,*,O
110162,31,Hospital1,O
110162,31,*,O
110162,31,*,O
110162,31,],O
110162,31,OU,O
110162,31,Xalatan,B-Drug
110162,31,QHS,O
110162,31,OS,O
110162,31,Tobradex,B-Drug
110162,31,OS,O
110162,31,QHS,O
110162,31,Discharge,O
110162,31,Medications,O
110162,31,:,O
110162,31,1,O
110162,31,.,O
110162,32,Latanoprost,B-Drug
110162,32,0.005,O
110162,32,%,O
110162,32,Drops,O
110162,32,Sig,O
110162,32,:,O
110162,32,One,O
110162,32,(,O
110162,32,1,O
110162,32,),O
110162,32,Drop,O
110162,32,Ophthalmic,O
110162,32,HS,O
110162,32,(,O
110162,32,at,O
110162,32,bedtime,O
110162,32,),O
110162,32,.,O
110162,32,2,O
110162,32,.,O
110162,32,Tobramycin-Dexamethasone,B-Drug
110162,32,0.3-0.1,O
110162,32,%,O
110162,32,Ointment,O
110162,32,Sig,O
110162,32,:,O
110162,32,One,O
110162,32,(,O
110162,32,1,O
110162,32,),O
110162,32,Appl,O
110162,32,Ophthalmic,O
110162,32,QHS,O
110162,32,(,O
110162,32,once,O
110162,32,a,O
110162,32,day,O
110162,32,(,O
110162,32,at,O
110162,32,bedtime,O
110162,32,),O
110162,32,),O
110162,32,.,O
110162,32,3,O
110162,32,.,O
110162,32,Timolol,B-Drug
110162,32,Maleate,I-Drug
110162,32,0.5,O
110162,32,%,O
110162,32,Drops,O
110162,32,Sig,O
110162,32,:,O
110162,32,One,O
110162,32,(,O
110162,32,1,O
110162,32,),O
110162,32,Drop,O
110162,32,Ophthalmic,O
110162,32,[,O
110162,32,*,O
110162,32,*,O
110162,32,Hospital1,O
110162,32,*,O
110162,32,*,O
110162,32,],O
110162,32,(,O
110162,32,2,O
110162,32,times,O
110162,32,a,O
110162,32,day,O
110162,32,),O
110162,32,.,O
110162,32,4,O
110162,32,.,O
110162,32,Prednisolone,B-Drug
110162,32,Acetate,I-Drug
110162,32,1,O
110162,32,%,O
110162,32,Drops,O
110162,32,",",O
110162,32,Suspension,O
110162,32,Sig,O
110162,32,:,O
110162,32,One,O
110162,32,(,O
110162,32,1,O
110162,32,),O
110162,32,Drop,O
110162,32,Ophthalmic,O
110162,32,DAILY,O
110162,32,(,O
110162,32,Daily,O
110162,32,),O
110162,32,.,O
110162,33,5,O
110162,33,.,O
110162,33,Atenolol,B-Drug
110162,33,25,O
110162,33,mg,O
110162,33,Tablet,O
110162,33,Sig,O
110162,33,:,O
110162,33,One,O
110162,33,(,O
110162,33,1,O
110162,33,),O
110162,33,Tablet,O
110162,33,PO,O
110162,33,DAILY,O
110162,33,(,O
110162,33,Daily,O
110162,33,),O
110162,33,.,O
110162,33,6,O
110162,33,.,O
110162,33,Carbidopa-Levodopa,B-Drug
110162,33,25-100,O
110162,33,mg,O
110162,33,Tablet,O
110162,33,Sig,O
110162,33,:,O
110162,33,One,O
110162,33,(,O
110162,33,1,O
110162,33,),O
110162,33,Tablet,O
110162,33,PO,O
110162,33,TID,O
110162,33,(,O
110162,33,3,O
110162,33,times,O
110162,33,a,O
110162,33,day,O
110162,33,),O
110162,33,.,O
110162,33,7,O
110162,33,.,O
110162,33,Levothyroxine,B-Drug
110162,33,125,O
110162,33,mcg,O
110162,33,Tablet,O
110162,33,Sig,O
110162,33,:,O
110162,33,One,O
110162,33,(,O
110162,33,1,O
110162,33,),O
110162,33,Tablet,O
110162,33,PO,O
110162,33,DAILY,O
110162,33,(,O
110162,33,Daily,O
110162,33,),O
110162,33,.,O
110162,33,8,O
110162,33,.,O
110162,33,Simvastatin,B-Drug
110162,33,10,O
110162,33,mg,O
110162,33,Tablet,O
110162,33,Sig,O
110162,33,:,O
110162,33,One,O
110162,33,(,O
110162,33,1,O
110162,33,),O
110162,33,Tablet,O
110162,33,PO,O
110162,33,DAILY,O
110162,33,(,O
110162,33,Daily,O
110162,33,),O
110162,33,.,O
110162,34,9,O
110162,34,.,O
110162,34,Docusate,B-Drug
110162,34,Sodium,I-Drug
110162,34,100,O
110162,34,mg,O
110162,34,Capsule,O
110162,34,Sig,O
110162,34,:,O
110162,34,One,O
110162,34,(,O
110162,34,1,O
110162,34,),O
110162,34,Capsule,O
110162,34,PO,O
110162,34,BID,O
110162,34,(,O
110162,34,2,O
110162,34,times,O
110162,34,a,O
110162,34,day,O
110162,34,),O
110162,34,.,O
110162,34,10,O
110162,34,.,O
110162,34,Senna,B-Drug
110162,34,8.6,O
110162,34,mg,O
110162,34,Tablet,O
110162,34,Sig,O
110162,34,:,O
110162,34,One,O
110162,34,(,O
110162,34,1,O
110162,34,),O
110162,34,Tablet,O
110162,34,PO,O
110162,34,BID,O
110162,34,(,O
110162,34,2,O
110162,34,times,O
110162,34,a,O
110162,34,day,O
110162,34,),O
110162,34,.,O
110162,34,11,O
110162,34,.,O
110162,34,Bisacodyl,B-Drug
110162,34,10,O
110162,34,mg,O
110162,34,Suppository,O
110162,34,Sig,O
110162,34,:,O
110162,34,One,O
110162,34,(,O
110162,34,1,O
110162,34,),O
110162,34,Suppository,O
110162,34,Rectal,O
110162,34,DAILY,O
110162,34,(,O
110162,34,Daily,O
110162,34,),O
110162,34,.,O
110162,34,12,O
110162,34,.,O
110162,34,Aspirin,B-Drug
110162,34,325,O
110162,34,mg,O
110162,34,Tablet,O
110162,34,Sig,O
110162,34,:,O
110162,34,One,O
110162,34,(,O
110162,34,1,O
110162,34,),O
110162,34,Tablet,O
110162,34,PO,O
110162,34,DAILY,O
110162,34,(,O
110162,34,Daily,O
110162,34,),O
110162,34,.,O
110162,35,13,O
110162,35,.,O
110162,35,Levetiracetam,B-Drug
110162,35,500,O
110162,35,mg,O
110162,35,Tablet,O
110162,35,Sig,O
110162,35,:,O
110162,35,Two,O
110162,35,(,O
110162,35,2,O
110162,35,),O
110162,35,Tablet,O
110162,35,PO,O
110162,35,BID,O
110162,35,(,O
110162,35,2,O
110162,35,times,O
110162,35,a,O
110162,35,day,O
110162,35,),O
110162,35,:,O
110162,35,for,O
110162,35,one,O
110162,35,week,O
110162,35,",",O
110162,35,then,O
110162,35,increase,O
110162,35,to,O
110162,35,1500mg,O
110162,35,[,O
110162,35,*,O
110162,35,*,O
110162,35,Hospital1,O
110162,35,*,O
110162,35,*,O
110162,35,],O
110162,35,.,O
110162,35,14,O
110162,35,.,O
110162,35,Augmentin,B-Drug
110162,35,875-125,O
110162,35,mg,O
110162,35,Tablet,O
110162,35,Sig,O
110162,35,:,O
110162,35,One,O
110162,35,(,O
110162,35,1,O
110162,35,),O
110162,35,Tablet,O
110162,35,PO,O
110162,35,twice,O
110162,35,a,O
110162,35,day,O
110162,35,for,O
110162,35,5,O
110162,35,days,O
110162,35,.,O
110162,35,Disp,O
110162,35,:,O
110162,35,*,O
110162,35,10,O
110162,35,Tablet,O
110162,35,(,O
110162,35,s,O
110162,35,),O
110162,35,*,O
110162,35,Refills,O
110162,35,:,O
110162,35,*,O
110162,35,0,O
110162,35,*,O
110162,35,Discharge,O
110162,35,Disposition,O
110162,35,:,O
110162,35,Extended,O
110162,35,Care,O
110162,35,Facility,O
110162,35,:,O
110162,35,[,O
110162,35,*,O
110162,35,*,O
110162,35,Hospital6,O
110162,35,459,O
110162,35,*,O
110162,35,*,O
110162,35,],O
110162,35,for,O
110162,35,the,O
110162,35,Aged,O
110162,35,-,O
110162,35,[,O
110162,35,*,O
110162,35,*,O
110162,35,Location,O
110162,35,(,O
110162,35,un,O
110162,35,),O
110162,35,550,O
110162,36,*,O
110162,36,*,O
110162,36,],O
110162,36,Discharge,O
110162,36,Diagnosis,O
110162,36,:,O
110162,36,Primary,O
110162,36,:,O
110162,36,oropharyngeal,O
110162,36,swelling,O
110162,36,",",O
110162,36,delirium,O
110162,36,",",O
110162,36,urinary,O
110162,36,tract,O
110162,36,infection,O
110162,36,Secondary,O
110162,36,:,O
110162,36,Parkinson,O
110162,36,'s,O
110162,36,disease,O
110162,36,",",O
110162,36,diabetes,O
110162,36,type,O
110162,36,2,O
110162,36,",",O
110162,36,hypertension,O
110162,36,",",O
110162,36,hyperlipidemia,O
110162,36,Discharge,O
110162,36,Condition,O
110162,36,:,O
110162,36,Good,O
110162,36,Discharge,O
110162,36,Instructions,O
110162,36,:,O
110162,36,You,O
110162,36,were,O
110162,36,evaluated,O
110162,36,for,O
110162,36,confusion,O
110162,36,and,O
110162,36,found,O
110162,36,to,O
110162,36,have,O
110162,36,swelling,O
110162,36,of,O
110162,36,your,O
110162,36,tongue,O
110162,36,and,O
110162,36,throat,O
110162,36,as,O
110162,36,well,O
110162,36,as,O
110162,36,a,O
110162,36,urinary,B-Reason
110162,36,tract,I-Reason
110162,36,infection,I-Reason
110162,36,.,O
110162,36,You,O
110162,36,improved,O
110162,36,with,O
110162,36,antibiotics,B-Drug
110162,36,.,O
110162,36,You,O
110162,36,became,O
110162,36,delirious,O
110162,36,in,O
110162,36,the,O
110162,36,hospital,O
110162,36,but,O
110162,36,improved,O
110162,36,with,O
110162,36,conservative,O
110162,36,treatment,O
110162,36,.,O
110162,37,If,O
110162,37,you,O
110162,37,have,O
110162,37,fevers,O
110162,37,",",O
110162,37,chills,O
110162,37,",",O
110162,37,confusion,O
110162,37,",",O
110162,37,or,O
110162,37,any,O
110162,37,other,O
110162,37,concerning,O
110162,37,symptoms,O
110162,37,",",O
110162,37,call,O
110162,37,your,O
110162,37,doctor,O
110162,37,.,O
110162,37,Followup,O
110162,37,Instructions,O
110162,37,:,O
110162,37,1,O
110162,37,.,O
110162,37,PCP,O
110162,37,",",O
110162,37,[,O
110162,37,*,O
110162,37,*,O
110162,37,Last,O
110162,37,Name,O
110162,37,(,O
110162,37,NamePattern4,O
110162,37,),O
110162,37,*,O
110162,37,*,O
110162,37,],O
110162,37,.,O
110162,37,[,O
110162,37,*,O
110162,37,*,O
110162,37,Last,O
110162,37,Name,O
110162,37,(,O
110162,37,STitle,O
110162,37,),O
110162,37,*,O
110162,37,*,O
110162,37,],O
110162,37,",",O
110162,37,ph,O
110162,37,:,O
110162,37,[,O
110162,37,*,O
110162,37,*,O
110162,37,Telephone/Fax,O
110162,37,(,O
110162,37,1,O
110162,37,),O
110162,37,250,O
110162,37,*,O
110162,37,*,O
110162,37,],O
110162,37,",",O
110162,37,please,O
110162,37,call,O
110162,37,and,O
110162,37,make,O
110162,37,appt,O
110162,37,for,O
110162,37,fu,O
110162,37,in,O
110162,37,[,O
110162,37,*,O
110162,37,*,O
110162,37,2-1,O
110162,37,*,O
110162,37,*,O
110162,37,],O
110162,37,weeks,O
110162,37,2,O
110162,37,.,O
110162,38,Ophtho,O
110162,38,",",O
110162,38,Dr.,O
110162,38,[,O
110162,38,*,O
110162,38,*,O
110162,38,Last,O
110162,38,Name,O
110162,38,(,O
110162,38,STitle,O
110162,38,),O
110162,38,*,O
110162,38,*,O
110162,38,],O
110162,38,",",O
110162,38,ph,O
110162,38,:,O
110162,38,[,O
110162,38,*,O
110162,38,*,O
110162,38,Telephone/Fax,O
110162,38,(,O
110162,38,1,O
110162,38,),O
110162,38,556,O
110162,38,*,O
110162,38,*,O
110162,38,],O
110162,38,",",O
110162,38,Appt,O
110162,38,is,O
110162,38,on,O
110162,38,[,O
110162,38,*,O
110162,38,*,O
110162,38,2119-4-28,O
110162,38,*,O
110162,38,*,O
110162,38,],O
110162,38,at,O
110162,38,11:00,O
110162,38,AM,O
110162,38,3,O
110162,38,.,O
110162,38,ENT,O
110162,38,",",O
110162,38,Dr.,O
110162,38,[,O
110162,38,*,O
110162,38,*,O
110162,38,Last,O
110162,38,Name,O
110162,38,(,O
110162,38,STitle,O
110162,38,),O
110162,38,*,O
110162,38,*,O
110162,38,],O
110162,38,",",O
110162,38,ph,O
110162,38,:,O
110162,38,[,O
110162,38,*,O
110162,38,*,O
110162,38,Telephone/Fax,O
110162,38,(,O
110162,38,1,O
110162,38,),O
110162,38,41,O
110162,38,*,O
110162,38,*,O
110162,38,],O
110162,38,",",O
110162,38,Appt,O
110162,38,is,O
110162,38,on,O
110162,38,[,O
110162,38,*,O
110162,38,*,O
110162,38,4-20,O
110162,38,*,O
110162,38,*,O
110162,38,],O
110162,38,",",O
110162,38,Thurs,O
110162,38,",",O
110162,38,12:00/noon,O
110162,38,4,O
110162,38,.,O
110162,39,Neurology,O
110162,39,",",O
110162,39,Dr.,O
110162,39,[,O
110162,39,*,O
110162,39,*,O
110162,39,Last,O
110162,39,Name,O
110162,39,(,O
110162,39,STitle,O
110162,39,),O
110162,39,557,O
110162,39,*,O
110162,39,*,O
110162,39,],O
110162,39,",",O
110162,39,ph,O
110162,39,:,O
110162,39,[,O
110162,39,*,O
110162,39,*,O
110162,39,Telephone/Fax,O
110162,39,(,O
110162,39,1,O
110162,39,),O
110162,39,558,O
110162,39,*,O
110162,39,*,O
110162,39,],O
110162,39,",",O
110162,39,Appt,O
110162,39,is,O
110162,39,on,O
110162,39,[,O
110162,39,*,O
110162,39,*,O
110162,39,5-9,O
110162,39,*,O
110162,39,*,O
110162,39,],O
110162,39,",",O
110162,39,Tuesday,O
110162,39,at,O
110162,39,9:30,O
110162,39,AM,O
